Bruce C Cozadd
Director at Jazz Pharmaceuticals plc (JAZZ)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $28.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 5SEC | JAZZJazz Pharmaceuticals plc | Sell Plan | 6,000345,875 held (−2%) | $230.33 | $1.4M | -5.2% |
| Sep 2SEC | JAZZJazz Pharmaceuticals plc | Sell Plan | 6,000351,875 held (−2%) | $250.13 | $1.5M | -12.7% |
| Aug 5SEC | JAZZJazz Pharmaceuticals plc | Sell Plan | 6,000360,682 held (−2%) | $252.98 | $1.5M | -13.7% |
| Jul 6SEC | JAZZJazz Pharmaceuticals plc | Sell Plan | 6,000366,682 held (−2%) | $240.47 | $1.4M | -9.2% |
| Jun 3SEC | JAZZJazz Pharmaceuticals plc | Sell Plan | 6,000372,682 held (−2%) | $235.12 | $1.4M | -7.1% |
| May 5SEC | JAZZJazz Pharmaceuticals plc | Sell Plan | 6,000378,682 held (−2%) | $203.33 | $1.2M | +7.4% |
| Apr 3SEC | JAZZJazz Pharmaceuticals plc | Sell Plan | 3,684386,998 held (−1%) | $190.22 | $701K | +14.8% |
| Apr 3SEC | JAZZJazz Pharmaceuticals plc | Sell Plan | 2,292384,706 held (−1%) | $190.94 | $438K | +14.4% |
| Apr 3SEC | JAZZJazz Pharmaceuticals plc | Sell Plan | 24384,682 held (−0%) | $191.74 | $5K | +13.9% |
| Mar 4SEC | JAZZJazz Pharmaceuticals plc | Sell Plan | 3,159408,637 held (−1%) | $186.09 | $588K | +17.4% |
| Mar 4SEC | JAZZJazz Pharmaceuticals plc | Sell Plan | 2,608406,029 held (−1%) | $186.73 | $487K | +17.0% |
| Mar 4SEC | JAZZJazz Pharmaceuticals plc | Sell Plan | 233405,796 held (−0%) | $187.84 | $44K | +16.3% |
| Dec 1SEC | JAZZJazz Pharmaceuticals plc | Sell | 30,487440,345 held (−6%) | $178.06 | $5.4M | +22.7% |
| Dec 1SEC | JAZZJazz Pharmaceuticals plc | Sell | 8,380431,965 held (−2%) | $179.23 | $1.5M | +21.9% |
| Dec 1SEC | JAZZJazz Pharmaceuticals plc | Sell | 507431,458 held (−0%) | $179.79 | $91K | +21.5% |
| Dec 1SEC | JAZZJazz Pharmaceuticals plc | Sell | 38,126393,332 held (−9%) | $177.27 | $6.8M | +23.2% |
| Nov 20SEC | JAZZJazz Pharmaceuticals plc | Sell | 3,384405,442 held (−1%) | $180.09 | $609K | +21.3% |
| Nov 20SEC | JAZZJazz Pharmaceuticals plc | Sell | 8,382397,060 held (−2%) | $180.88 | $1.5M | +20.8% |
| Nov 20SEC | JAZZJazz Pharmaceuticals plc | Sell | 5,517391,543 held (−1%) | $181.81 | $1.0M | +20.1% |
| Nov 20SEC | JAZZJazz Pharmaceuticals plc | Sell | 717390,826 held (−0%) | $182.60 | $131K | +19.6% |
| Oct 3SEC | JAZZJazz Pharmaceuticals plc | Sell Plan | 2,000412,326 held (−0%) | $131.78 | $264K | +65.7% |
| Oct 3SEC | JAZZJazz Pharmaceuticals plc | Sell Plan | 3,500408,826 held (−1%) | $140.00 | $490K | +56.0% |
- Sell
Director Bruce C Cozadd sold $1.4M of JAZZ at $230.33 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Bruce C Cozadd sold $1.5M of JAZZ at $250.13 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Bruce C Cozadd sold $1.5M of JAZZ at $252.98 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Bruce C Cozadd sold $1.4M of JAZZ at $240.47 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Bruce C Cozadd sold $1.4M of JAZZ at $235.12 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Bruce C Cozadd sold $1.2M of JAZZ at $203.33 — pre-scheduled 10b5-1 plan sale.